Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine. [electronic resource]
Producer: 19970121Description: 3270-1 p. digitalISSN:- 0041-1345
- Abatacept
- Animals
- Antigens, CD
- Antigens, Differentiation -- therapeutic use
- CTLA-4 Antigen
- Cyclosporine -- therapeutic use
- Drug Therapy, Combination
- Graft Survival -- drug effects
- Immunoconjugates
- Immunosuppressive Agents -- therapeutic use
- Mice
- Mice, Inbred C3H
- Mice, Inbred Strains
- Polyenes -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Sirolimus
- Skin Transplantation -- immunology
- Time Factors
- Transplantation, Homologous
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.